These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 26721949)

  • 1. Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression.
    Udina M; Navinés R; Egmond E; Oriolo G; Langohr K; Gimenez D; Valdés M; Gómez-Gil E; Grande I; Gratacós M; Kapczinski F; Artigas F; Vieta E; Solà R; Martín-Santos R
    Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26721949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C.
    Kraus MR; Al-Taie O; Schäfer A; Pfersdorff M; Lesch KP; Scheurlen M
    Gastroenterology; 2007 Apr; 132(4):1279-86. PubMed ID: 17408646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.
    Udina M; Moreno-España J; Navinés R; Giménez D; Langohr K; Gratacòs M; Capuron L; de la Torre R; Solà R; Martín-Santos R
    Psychoneuroendocrinology; 2013 Sep; 38(9):1803-13. PubMed ID: 23571152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin gene polymorphisms and lifetime mood disorders in predicting interferon-induced depression in chronic hepatitis C.
    Cozzolongo R; Porcelli P; Cariola F; Giannuzzi V; Lanzilotta E; Gentile M; Sonnante G; Leandro G
    J Affect Disord; 2015 Sep; 183():90-7. PubMed ID: 26001668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.
    Galvão-de Almeida A; Quarantini LC; Sampaio AS; Lyra AC; Parise CL; Paraná R; de Oliveira IR; Koenen KC; Miranda-Scippa A; Guindalini C
    Brain Behav Immun; 2011 Oct; 25(7):1491-7. PubMed ID: 21693183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C.
    Smith AK; Simon JS; Gustafson EL; Noviello S; Cubells JF; Epstein MP; Devlin DJ; Qiu P; Albrecht JK; Brass CA; Sulkowski MS; McHutchinson JG; Miller AH
    Mol Psychiatry; 2012 Jul; 17(8):781-9. PubMed ID: 21691274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated interferon and ribavirin-induced depression in chronic hepatitis C: role of personality.
    Castellvi P; Navinés R; Gutierrez F; Jiménez D; Márquez C; Subirà S; Solà R; Martín-Santos R
    J Clin Psychiatry; 2009 Jun; 70(6):817-28. PubMed ID: 19573480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Associations of Alexithymia in Predicting Interferon-Induced Depression in Chronic Hepatitis C.
    Porcelli P; Cozzolongo R; Cariola F; Giannuzzi V; Lanzilotta E; Gentile M; Sonnante G; Leandro G
    Psychopathology; 2015; 48(6):417-20. PubMed ID: 26609890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL28B and IL10R -1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohort.
    Pár A; Pár G; Tornai I; Szalay F; Várszegi D; Fráter E; Papp M; Lengyel G; Fehér J; Varga M; Gervain J; Schuller J; Nemes Z; Péterfi Z; Tusnádi A; Hunyady B; Haragh A; Szinku Z; Vincze A; Szereday L; Kisfali P; Melegh B
    BMC Res Notes; 2014 Jan; 7():12. PubMed ID: 24398031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites during Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV).
    Pawlowski T; Malyszczak K; Pawlak D; Inglot M; Zalewska M; Grzywacz A; Radkowski M; Laskus T; Janocha-Litwin J; Frydecka D
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment.
    Lotrich FE; Albusaysi S; Ferrell RE
    Neuropsychopharmacology; 2013 May; 38(6):985-95. PubMed ID: 23303061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C.
    Cieśla A; Bociąga-Jasik M; Sobczyk-Krupiarz I; Głowacki MK; Owczarek D; Cibor D; Sanak M; Mach T
    World J Gastroenterol; 2012 Sep; 18(35):4892-7. PubMed ID: 23002361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in 5-HTTLPR, BDNF, HTR1A, COMT, and FKBP5 and risk for treated depression after cancer diagnosis.
    Suppli NP; Bukh JD; Moffitt TE; Caspi A; Johansen C; Tjønneland A; Kessing LV; Dalton SO
    Depress Anxiety; 2017 Sep; 34(9):845-855. PubMed ID: 28590587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-λ-related genes and therapeutic response in Chinese hepatitis C patients.
    Zhang YY; Chen HB; Xu Y; Huang P; Wang J; Zhang Y; Yu RB; Su J
    World J Gastroenterol; 2015 Apr; 21(13):4006-13. PubMed ID: 25852288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
    Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
    Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single nucleotide polymorphism in IL28B affects viral evolution of hepatitis C quasispecies after pegylated interferon and ribavirin therapy.
    Yuan H; Adams-Huet B; Petersen T; Attar N; Lee WM; Jain MK
    J Med Virol; 2012 Dec; 84(12):1913-9. PubMed ID: 23080496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.
    Comai S; Cavalletto L; Chemello L; Bernardinello E; Ragazzi E; Costa CV; Bertazzo A
    Pharmacol Res; 2011 Jan; 63(1):85-92. PubMed ID: 20940053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [IL28B CC genotype: a protective factor and predictor of the response to interferon treatment in chronic hepatitis C virus infection].
    Pár A; Pár G; Tornai I; Szalay F; Várszegi D; Fráter E; Papp M; Lengyel G; Fehér J; Varga M; Gervain J; Schuller J; Nemes Z; Péterfi Z; Tusnádi A; Hunyady B; Haragh A; Szinku Z; Pálinkás L; Berki T; Vincze A; Kisfali P; Melegh B
    Orv Hetil; 2013 Aug; 154(32):1261-8. PubMed ID: 23916907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin.
    Hayashi K; Katano Y; Kuzuya T; Tachi Y; Honda T; Ishigami M; Itoh A; Hirooka Y; Ishikawa T; Nakano I; Urano F; Yoshioka K; Toyoda H; Kumada T; Goto H
    J Med Virol; 2012 Mar; 84(3):438-44. PubMed ID: 22246829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype.
    Itokawa N; Atsukawa M; Tsubota A; Kondo C; Hashimoto S; Fukuda T; Matsushita Y; Kidokoro H; Kobayashi T; Narahara Y; Nakatsuka K; Kanazawa H; Iwakiri K; Sakamoto C
    J Gastroenterol Hepatol; 2013 Mar; 28(3):443-9. PubMed ID: 23173698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.